Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 179.90
Change Today 0.00 / 0.00%
Volume 0.0
As of 10:24 AM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

allium medical solutions ltd (ALMD) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/2/14 - $250.27
52 Week Low
03/18/15 - $94.59
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

allium medical solutions ltd (ALMD) Related Businessweek News

No Related Businessweek News Found

allium medical solutions ltd (ALMD) Details

Allium Medical Solutions Ltd., a medical device company, develops, manufactures, and markets minimally invasive products in Israel and internationally. It offers urology products, such as ureteral, round posterior, triangular prostatic, and bulbar stents; and gastroenterology products, including biliary stents for use in chronic Common Bile Duct obstructions for allowing intra-luminal flow. The company also provides uro-gynecology products consisting of EndoFast Reliant Systems for reinforcement of the vaginal wall; EndoFast Resorb kits for fixation of surgical mesh to tissues for tissue reinforcement; EndoFast Reliant MN, an implantable, sub-urethral support sling for the treatment of male stress urinary incontinence; and EndoFast Reliant SCP for fixation of surgical mesh to tissue for tissue reinforcement during laparotomy or laparoscopic Sacrocolpopexy approach. In addition, it offers cardiovascular products comprising WIRION, a distal embolic protection system. The company is headquartered in Caesarea, Israel.

Founded in 2001

allium medical solutions ltd (ALMD) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

allium medical solutions ltd (ALMD) Key Developments

Allium Medical's Gardia Successfully Met All Clinical Study Endpoints Set by the FDA

Allium Medical announced that the FDA confirmed Gardia successfully achieved all the clinical study objectives at the early stage of recruitment of half the number of patients (120 patients out of 240), based on the interim results. According to the study protocol, in order to meet the primary end-point of the study, which is the safety profile, already at this early stage, the Company was required to meet very stringent statistical criteria in relation to the statistical criteria required for the full study. In view of the successful compliance with all clinical trial objectives at this early stage, the Company decided to stop recruiting additional patients. The Gardia WIRION system, which has been used successfully in over 250 procedures, in a variety of clinical indications, received a very favorable feedback from leading European physicians performing these procedures. The system includes significant competitive advantages over other FDA cleared products of other companies. The WIRION system is a unique, patent-protected embolic protection filter system that provides protection from blood clots and emboli produced during catheterization procedures for the opening of blocked blood vessels. The system has a unique locking mechanism that allows the physician to use any guide wire of choice and place the filter at a desired location. The flexibility to place the filter anywhere over any guide wire of choice makes the procedure more safe, convenient and simple for use, thus presenting significant advantages with respect to other protection solutions available in the market.

Allium Medical Solutions Ltd. Auditor Raises 'Going Concern' Doubt

Allium Medical Solutions Ltd. filed its Annual on Mar 12, 2015 for the period ending Dec 31, 2014. In this report its auditor, Kesselman & Kesselman, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Allium Medical Solutions Ltd., Special/Extraordinary Shareholders Meeting, Feb 15, 2015

Allium Medical Solutions Ltd., Special/Extraordinary Shareholders Meeting, Feb 15, 2015., at 11:00 Israel Standard Time.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALMD:IT 179.90 0.00

ALMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALMD.
View Industry Companies

Industry Analysis


Industry Average

Valuation ALMD Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALLIUM MEDICAL SOLUTIONS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at